Key result
Incident ventricular tachycardia significantly increased the risk of in-hospital mortality among hospitalized COVID-19 patients (RR 2.55; P=0.003), whereas incident atrial fibrillation did not.
Why the study?
Little was known regarding the prognostic impact, incidence, and predictors of incident sustained tachyarrhythmias in hospitalized COVID-19 patients, as well as their association with disease severity and in-hospital mortality.
Do incident sustained tachyarrhythmias increase the risk of ARDS and in-hospital mortality in hospitalized COVID-19 patients?
Observational (n=414)
Yes
Do incident sustained tachyarrhythmias increase the risk of ARDS and in-hospital mortality in hospitalized COVID-19 patients?
Relative Risk: 2.55
p-value: p=.003
In hospitalized COVID-19 patients, incident ventricular tachycardia is an independent predictor of in-hospital mortality, whereas incident atrial fibrillation is not associated with increased mortality or ARDS.
May prompt enhanced VT monitoring in hospitalized COVID-19; leaves open whether targeted interventions improve survival.
INTRODUCTION: Little is still known about the prognostic impact of incident arrhythmias in hospitalized patients with COVID-19. The aim of this study was to evaluate the incidence and predictors of sustained tachyarrhythmias in hospitalized patients with COVID-19, and their potential association with disease severity and in-hospital mortality. MATERIALS AND METHODS: This was a retrospective multicenter observation study including consecutive patients with laboratory confirmed COVID-19 admitted to emergency department of ten Italian Hospitals from 15 February to 15 March 2020. The prevalence and the type of incident sustained arrhythmias have been collected. The correlation between the most prevalent arrhythmias and both baseline characteristics and the development of ARDS and in-hospital mortality has been evaluated. RESULTS: 414 hospitalized patients with COVID-19 (66.9 ± 15.0 years, 61.1% male) were included in the present study. During a median follow-up of 28 days (IQR: 12-45), the most frequent incident sustained arrhythmia was AF (N: 71; 17.1%), of which 50 (12.1%) were new-onset and 21 (5.1%) were recurrent, followed by VT (N: 14, 3.4%) and supraventricular arrhythmias (N: 5, 1.2%). Incident AF, both new-onset and recurrent, did not affect the risk of severe adverse events including ARDS and death during hospitalization; in contrast, incident VT significantly increased the risk of in-hospital mortality (RR: 2.55; P: .003). CONCLUSIONS: AF is the more frequent incident tachyarrhythmia; however, it not seems associated to ARDS development and death. On the other hand, incident VT is a not frequent but independent predictor of in-hospital mortality among hospitalized COVID-19 patients.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2020) conducted an observational in COVID-19 (n=414). Incident sustained tachyarrhythmias (AF and VT) vs. No incident tachyarrhythmia was evaluated on In-hospital mortality (RR 2.55, p=.003). Incident ventricular tachycardia significantly increased the risk of in-hospital mortality among hospitalized COVID-19 patients (RR 2.55; P=0.003), whereas incident atrial fibrillation did not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: